An Italian group recently reported results wherein a cohort of lung cancer cytological specimens where analysed using the IdyllaTM EGFR Mutation assay (Biocartis), which detects 53 different mutations (point mutations, insertions and deletions) using integrated PlexPrime/PlexZyme technology. The gene discussed is EGFR; the disease is lung carcinoma.